Role of apoptotic regulators in human epithelial ovarian cancer

被引:31
作者
Kar, Rajarshi
Sen, Sudip
Singh, Archna
Sharma, Himani
Kumar, Sunesh
Gupta, Siddhartha Dutta
Singh, Neeta
机构
[1] All India Inst Med Sci, Dept Biochem, New Delhi 110029, India
[2] All India Inst Med Sci, Dept Obstet & Gynecol, New Delhi 110029, India
[3] All India Inst Med Sci, Dept Pathol, New Delhi 110029, India
关键词
ovarian cancer; apoptotic index; telomerase activity; ascitic cells; Bcl-2; family; BRCA1; survivin;
D O I
10.4161/cbt.6.7.4329
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We assessed molecular markers such as BRCA1, K-ras, p53, Bcl-2, Bcl-XL, Survivin and telomerase activity in untreated ovarian cancer tissue samples, ascitic cells and normal ovarian tissues and gathered insights into their correlation with each other and also with apoptotic index. The expression of these proteins was analyzed by Western blotting and immunohistochemistry. Apoptotic index was determined by TUNEL assay and telomerase activity was measured by PCR-ELISA kit. p53, Bcl-2, Bcl-XL, K-ras and Survivin were found to be over expressed in tumors and ascitic cells as compared to normal controls whereas there was no significant difference in expression of BRCA1. A significantly higher telomerase activity and lower apoptotic index in tumors as compared to controls was observed. p53 positively correlated with Bcl-2, Bcl-XL, K-ras and Survivin expression and also clinical stage of the disease. A positive correlation between Survivin and Bcl-2, Bcl-XL was seen. Apoptotic Index, telomerase activity and BRCA1 expression showed no correlation with any of the parameters. Our study confirms the fact that multiple gene interactions govern the pathogenesis of ovarian cancer, and analyzing ascitic cells of ovarian cancer patients may help to delineate molecular profile of the primary tumor.
引用
收藏
页码:1101 / 1105
页数:5
相关论文
共 23 条
[1]   Human ovarian cancer of the surface epithelium [J].
Berchuck, A ;
Carney, M .
BIOCHEMICAL PHARMACOLOGY, 1997, 54 (05) :541-544
[2]   Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers [J].
Chan, WY ;
Cheung, KK ;
Schorge, JO ;
Huang, LW ;
Welch, WR ;
Bell, DA ;
Berkowitz, RS ;
Mok, SC .
AMERICAN JOURNAL OF PATHOLOGY, 2000, 156 (02) :409-417
[3]   Survivin expression in ovarian carcinoma: Correlation with apoptotic markers and prognosis [J].
Cohen, C ;
Lohmann, CM ;
Cotsonis, G ;
Lawson, D ;
Santoianni, R .
MODERN PATHOLOGY, 2003, 16 (06) :574-583
[4]   Molecular prognostic markers in ovarian cancer: toward patient-tailored therapy [J].
Crijns, APG ;
Duiker, EW ;
de Jong, S ;
Willemse, PHB ;
van der Zee, AGJ ;
de Vries, EGE .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2006, 16 :152-165
[5]  
Cuatrecasas M, 1998, CANCER-AM CANCER SOC, V82, P1088
[6]   Effusion cytology in ovarian cancer: new molecular methods as aids to diagnosis and prognosis [J].
Davidson, B ;
Risberg, B ;
Reich, R ;
Berner, A .
CLINICS IN LABORATORY MEDICINE, 2003, 23 (03) :729-+
[7]  
Diebold J, 1996, AM J CLIN PATHOL, V105, P341
[8]   Neoadjuvant chemotherapy for epithelial ovarian cancer - role of apoptosis [J].
Dutta, T ;
Sharma, H ;
Kumar, L ;
Dinda, AK ;
Kumar, S ;
Bhatla, N ;
Singh, N .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2005, 56 (04) :427-435
[9]   Telomerase activity determined by conventional telomeric repeat amplification protocol and reverse transcriptase-polymerase chain reaction assay in ovarian lesions: A comparison of assays [J].
Ernst, A. ;
Okkels, H. ;
Grove, A. ;
Svarrer, T. ;
Knudsen, A. ;
Madsen, P. H. ;
Krarup, H. B. .
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2006, 66 (04) :287-297
[10]   Gene expression profiles, of BRCA1-linked, BRCA2-linked, and sporadic ovarian cancers [J].
Jazaeri, AA ;
Yee, CJ ;
Sotiriou, C ;
Brantley, KR ;
Boyd, J ;
Liu, ET .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (13) :990-1000